PERSPECTA

News from every angle

← Back to headlines

BioNTech founders launch new mRNA company after billion-euro loss

The co-founders and top executives of Germany's BioNTech, known for its COVID-19 vaccine, will leave the company by the end of 2026 to establish a new venture, following a billion-euro loss.

10 Mar, 13:00 — 10 Mar, 13:04
PostShare

The Story

Analyzing sources…

Source Diversity

Source Diversity

Moderate (32/100)
2 sources— more sources would strengthen this score15/33
Spectrum spread2/5 buckets covered8/33
Far L
Left
Center
Right1
Right (1)
die-presse
Far R1
Far Right (1)
Daily Sabah
Geographic diversity2 regions9/34
Turkey1Austria1
Only 2 sources cover this story

Coverage Timeline

First report: die-presse · 10 Mar, 13:00Full coverage: All 2 sources within 3mWindow: 3m
Left-leaningCenterRight-leaning